Faron Pharmaceuticals Oy (FARN) News Today GBX 168 +3.00 (+1.82%) (As of 12/20/2024 10:05 AM ET) Add Compare Share Share Headlines Stock AnalysisChartCompetitorsHeadlines All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period Faron Pharmaceuticals Reports Promising BEXMAB Trial ResultsDecember 11, 2024 | markets.businessinsider.comFaron Pharma CEO talks about MHRA fast-track and phase III plans - ICYMIDecember 7, 2024 | uk.investing.comFaron Pharmaceuticals Oy (LON:FARN) Shares Up 1.3% - Still a Buy?Faron Pharmaceuticals Oy (LON:FARN) Trading Up 1.3% - Should You Buy?December 5, 2024 | marketbeat.comFaron Pharma secures UK innovation passport for blood cancer immunotherapyDecember 4, 2024 | msn.comFaron Pharmaceuticals Share Chat (FARN)December 2, 2024 | lse.co.ukFaron Pharmaceuticals Oy (LON:FARN) Stock Price Crosses Below 50-Day Moving Average - Time to Sell?Faron Pharmaceuticals Oy (LON:FARN) Stock Price Passes Below Fifty Day Moving Average - What's Next?November 13, 2024 | marketbeat.comFaron Pharmaceuticals Expands Pipeline with New PatentNovember 11, 2024 | msn.comFaron Pharmaceuticals Oy (LON:FARN) Share Price Passes Below 50 Day Moving Average - Here's WhyFaron Pharmaceuticals Oy (LON:FARN) Stock Passes Below Fifty Day Moving Average - Here's WhyOctober 24, 2024 | marketbeat.comFaron Pharmaceuticals Oy (LON:FARN) Share Price Crosses Above 50 Day Moving Average of $182.05Faron Pharmaceuticals Oy (LON:FARN) Shares Cross Above Fifty Day Moving Average of $182.05September 21, 2024 | marketbeat.comFaron Pharmaceuticals Oy (LON:FARN) Shares Down 8.8% Faron Pharmaceuticals Oy (LON:FARN) Shares Down 8.8%August 28, 2024 | marketbeat.comFaron Pharmaceuticals Oy (LON:FARN) Stock Price Up 27.3%Faron Pharmaceuticals Oy (LON:FARN) Trading Up 27.3%August 27, 2024 | marketbeat.comFaron Pharmaceuticals Share ChatJuly 31, 2024 | lse.co.ukFaron Pharmaceuticals Oy Appoints Juho Jalkanen as CEOApril 30, 2024 | marketwatch.comFaron Pharmaceuticals Oy: Faron Confirms Plans for the Coming Months Under New LeadershipApril 16, 2024 | finanznachrichten.deFaron Confirms Plans for the Coming Months Under New LeadershipApril 16, 2024 | finance.yahoo.comInside Information: Additional Positive Data from the Phase 1 Part of the BEXMAB Study in Both Higher-Risk HMA-Failed MDS and r/r AMLMarch 18, 2024 | finance.yahoo.comFaron Pharmaceuticals reports promising phase 1 results from BEXMAB studyMarch 18, 2024 | finance.yahoo.comFaron to Host Webcast to Discuss latest data from Phase 1 part of the BEXMAB Study of BexmarilimabMarch 14, 2024 | finance.yahoo.comFaron’s Financial Statement Release January 1 to December 31, 2023March 13, 2024 | finance.yahoo.comFaron Pharma secures €3.2 million convertible loanMarch 4, 2024 | uk.investing.comNasdaq Helsinki Ltd: THE SHARES OF FARON PHARMACEUTICALS LTD. GIVEN OBSERVATION STATUSFebruary 19, 2024 | finanznachrichten.deFaron Pharmaceuticals Oy (FARN)February 1, 2024 | uk.investing.comFaron Pharmaceuticals Oy: Detailed Analysis of BEXMAB Data Provides Insights into Patient Profiles of Responding HMA-Failed MDS PopulationJanuary 25, 2024 | finanznachrichten.deDetailed Analysis of BEXMAB Data Provides Insights into Patient Profiles of Responding HMA-Failed MDS PopulationJanuary 25, 2024 | finance.yahoo.comFaron Pharmaceuticals Oy (FARN.L)January 23, 2024 | finance.yahoo.comFaron Pharmaceuticals Oy: Inside information: Faron Announces First HMA-failed MDS Patient Dosed with Bexmarilimab as part of Phase 2 of BEXMAB TrialJanuary 11, 2024 | finanznachrichten.deFaron Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare ConferenceJanuary 3, 2024 | finance.yahoo.comFaron Pharmaceuticals presents "very positive" Phase 1 data at ASH ConferenceDecember 11, 2023 | finance.yahoo.comFaron Pharmaceuticals hails positive results of cancer drug trialDecember 11, 2023 | lse.co.ukInside information: Faron Presents Phase 1 Data from BEXMAB in Myeloid Malignancies Trial at the 65th American Society of Hematology (ASH) Annual MeetingDecember 11, 2023 | finance.yahoo.comFaron Announces Publication of Full Analysis from Phase 1/2 MATINS Trial of Bexmarilimab in Solid Tumors in Cell Reports MedicineDecember 7, 2023 | finance.yahoo.comFaron Pharmaceuticals Oy FARNNovember 24, 2023 | morningstar.comFaron Pharmaceuticals initiates second phase of BEXMAB studyNovember 6, 2023 | finance.yahoo.comFaron Pharmaceuticals Oy's (LON:FARN) last week's 11% decline must have disappointed individual investors who have a significant stakeNovember 6, 2023 | finance.yahoo.comFaron to Present Phase 1/2 Data From BEXMAB Study of Bexmarilimab in Combination with Standard of Care in Myeloid Malignancies at the 65th American Society of Hematology Annual MeetingNovember 2, 2023 | finance.yahoo.comFaron Pharma raises €7.1m as cancer study continues apaceOctober 27, 2023 | proactiveinvestors.comInside Information: Announcement of the Results of Placing, the Issue Price and registration of Placing Shares with the Trade RegisterOctober 27, 2023 | finance.yahoo.comFaron Pharmaceuticals' chief speaks after latest promising BEXMAB trial dataOctober 16, 2023 | proactiveinvestors.comFaron Pharma data 'extremely encouraging', says CEOOctober 11, 2023 | proactiveinvestors.comFaron Pharmaceuticals data 'highly encouraging', say bankOctober 11, 2023 | proactiveinvestors.comInside information: Faron Announces Positive BEXMAB Study Update in Relapsed/Refractory AML and HMA-Refractory MDS PatientsOctober 11, 2023 | finance.yahoo.comFaron to Host Webcast to Discuss New Data From Phase I/II BEXMAB Study of Bexmarilimab and Provide Update on the Development Outlook for Next 6-9 MonthsOctober 3, 2023 | finance.yahoo.comBreakeven On The Horizon For Faron Pharmaceuticals Oy (LON:FARN)September 26, 2023 | finance.yahoo.comFaron Pharmaceuticals Ltd Results of the Extraordinary General MeetingSeptember 22, 2023 | markets.businessinsider.comFaron Pharmaceuticals Announces Board ChangesSeptember 22, 2023 | finance.yahoo.comFaron Pharmaceuticals Ltd Results of the Extraordinary General MeetingSeptember 22, 2023 | finance.yahoo.comBRIEF-Faron Pharmaceuticals Appoints Birge Berns As Interim Chief Medical OfficerSeptember 21, 2023 | reuters.comFaron Pharma appoints new chief medical officerSeptember 21, 2023 | proactiveinvestors.comFaron Pharmaceuticals Oy: Faron Appoints Dr. Birge Berns, MD as Interim Chief Medical OfficerSeptember 21, 2023 | finanznachrichten.deFaron Appoints Dr. Birge Berns, MD as Interim Chief Medical OfficerSeptember 21, 2023 | finance.yahoo.com Get Faron Pharmaceuticals Oy News Delivered to You Automatically Sign up to receive the latest news and ratings for FARN and its competitors with MarketBeat's FREE daily newsletter. Email Address Could This Tiny Device Help You Make an Extra $30k a Year? (Ad)I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more than $9 trillion. That’s nearly 10 times more money than the market caps of Tesla… SpaceX… PayPal… Neuralink… and X… COMBINED. Click here to see the details because I believe a lot of people will get rich. FARN Media Mentions By Week FARN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. FARN News Sentiment▼0.000.60▲Average Medical News Sentiment FARN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. FARN Articles This Week▼00▲FARN Articles Average Week Get Faron Pharmaceuticals Oy News Delivered to You Automatically Sign up to receive the latest news and ratings for FARN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Oxford Biomedica News PureTech Health News Bioventix News Arix Bioscience News Avacta Group News 4basebio News hVIVO News Scancell News Futura Medical News Redx Pharma News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (LON:FARN) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Faron Pharmaceuticals Oy Please log in to your account or sign up in order to add this asset to your watchlist. Share Faron Pharmaceuticals Oy With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
